Olszewski Recaps Results of Mosunetuzumab in Elderly/Unfit D

Adam J. Olszewski, MD, discusses the promising results of a phase 1b/2 study of mosunetuzumab for elderly/unfit patients with previously untreated diffuse large B-cell lymphoma.

Related Keywords

Brown University , Rhode Island , United States , Rhode Island Hospital , Adamj Olszewski , , News , Videos , Dlbcl , D , Elderly Unfit Patients With Previously Untreated Diffuse Largeb Cell Lymphoma , Diffuse Largeb Cell Lymphoma , Lymphoma , Nct03677154 , Phase 1b 2 Study Nct03677154 , Mosunetuzumab , Lunsumio ,